4//SEC Filing
Poradosu Enrique 4
Accession 0001104659-24-120876
CIK 0001875558other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:30 AM ET
Size
5.4 KB
Accession
0001104659-24-120876
Insider Transaction Report
Form 4
Poradosu Enrique
Chief Science & Business Off
Transactions
- Purchase
Common Stock
2024-11-19$4.99/sh+2,000$9,980→ 1,506,319 total
Footnotes (2)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $4.98 to $4.99. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Includes 353,399 shares of restricted stock.
Documents
Issuer
Nuvectis Pharma, Inc.
CIK 0001875558
Entity typeother
Related Parties
1- filerCIK 0001898147
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 8:30 AM ET
- Size
- 5.4 KB